Alpha Teknova (TKNO) Capital Expenditures (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Capital Expenditures of $221000.0 for Q1 2026, up 7.28% year-over-year from $206000.0 in Q1 2025, and down 36.49% quarter-over-quarter from $348000.0 in Q4 2025.
Alpha Teknova (TKNO) Capital Expenditures (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Capital Expenditures for 7 consecutive years, with $221000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures rose 7.28% year-over-year to $221000.0; the TTM figure through Mar 2026 stood at $1.2 million (down 4.59% YoY), while the FY2025 annual figure was $1.1 million, up 2.04% from the prior year.
- Capital Expenditures slipped to $221000.0 in Q1 2026 per TKNO's latest filing, from $348000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $10.9 million in Q2 2022 and bottomed at $112000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $2.3 million across 5 years, with a median of $387000.0 in 2025.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 133.63% — and 2024, when it tumbled 97.4%.
- Alpha Teknova's Capital Expenditures stood at $4.7 million in 2022, then slumped by 93.4% to $312000.0 in 2023, then jumped by 81.73% to $567000.0 in 2024, then slumped by 38.62% to $348000.0 in 2025, then sank by 36.49% to $221000.0 in 2026.
- Business Quant data shows TKNO's Capital Expenditures at $221000.0 in Q1 2026, $348000.0 in Q4 2025, and $387000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Jun 30, 2026 | 125,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Dec 31, 2024 | 567,000.00 |
| Dec 31, 2024 | 567,000.00 |
| Sep 30, 2024 | 331,000.00 |
| Sep 30, 2024 | 331,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Mar 31, 2024 | 112,000.00 |